RegeneRx Biopharmaceuticals (RGRX)
OTHER OTC:RGRX
US Market
Holding RGRX?
Track your performance easily

RegeneRx Biopharmaceuticals (RGRX) Financial Statements

82 Followers

RegeneRx Biopharmaceuticals Financial Overview

RegeneRx Biopharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; RegeneRx Biopharmaceuticals is scheduled to report earnings on May 15, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 23Dec 22Sep 22Jun 22Mar 22
Income Statement-
Total Revenue$ 19.19K$ 19.19K$ 19.19K$ 19.19K$ 19.19K
Gross Profit$ 19.19K$ 19.19K$ 19.19K$ 19.19K$ 19.19K
EBIT$ -304.90K$ -308.82K$ -284.43K$ -464.79K$ -343.77K
EBITDA$ -304.90K$ -308.82K$ -284.43K$ -464.79K$ -343.77K
Net Income Common Stockholders$ -385.20K$ -390.91K$ -366.51K$ -545.98K$ -424.06K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 101.56K$ 290.89K$ 478.41K$ 706.65K$ 925.30K
Total Assets$ 186.81K$ 382.18K$ 580.99K$ 735.50K$ 960.53K
Total Debt$ 1.23M$ 73.56K$ 75.29K$ 4.17K$ 16.28K
Net Debt$ 1.13M$ -217.33K$ -403.12K$ -702.48K$ -909.02K
Total Liabilities$ 3.93M$ 3.83M$ 3.72M$ 3.60M$ 3.53M
Stockholders Equity$ -3.74M$ -3.45M$ -3.14M$ -2.86M$ -2.57M
Cash Flow-
Free Cash Flow$ -189.33K$ -187.52K$ -228.24K$ -218.66K$ -306.30K
Operating Cash Flow$ -189.33K$ -187.52K$ -228.24K$ -218.66K$ -306.30K
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

RegeneRx Biopharmaceuticals Earnings and Revenue History

RegeneRx Biopharmaceuticals Debt to Assets

RegeneRx Biopharmaceuticals Cash Flow

RegeneRx Biopharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis